menu
Over 115 companies located in various regions across the globe claim to provide contract fill / finish services for various types of biopharmaceutical drug / therapy products, claims Roots Analysis
Over 115 companies located in various regions across the globe claim to provide contract fill / finish services for various types of biopharmaceutical drug / therapy products, claims Roots Analysis
Despite the fact that biopharmaceuticals offer significant profit margins, innovator companies are plagued by high costs of development, complex production protocols and special procedures and equipment for fill / finish operations.

Over 115 companies located in various regions across the globe claim to provide contract fill / finish services for various types of biopharmaceutical drug / therapy products, claims Roots Analysis

Despite the fact thatbiopharmaceuticals offer significant profit margins, innovator companies areplagued by high costs of development, complex production protocols and specialprocedures and equipment for fill / finish operations. Consequently, a numberof drug manufacturers have demonstrated a preference for outsourcing fill /finish operations of such products.

 

To order this 480+ page report, which features 350+ figuresand 260+ tables, please visit this link

 

The USD 4.2 billion(by 2030) financial opportunity within the biologics fill / finish services markethas been analyzed across the following segments:

§ Types of PrimaryPackaging Containers

§ Ampoules

§ Cartridges

§ Syringes

§ Vials

 

§ Types of Biologics

§ Peptides / proteins

§ Antibodies

§ Vaccines

§ Cell therapies

§ Gene therapies

§ Viral products

§ Oligonucleotides

§ Others

 

§ Company Size

§ Small-sized

§ Mid-sized

§ Large / very large

 

§ Scale of Operation

§ Preclinical

§ Clinical

§ Commercial

 

§ Key Therapeutic Areas

§ Cancer

§ Infectious diseases

§ Autoimmune diseases

§ Cardiovasculardiseases

§ Other indications

 

§ Key GeographicalRegions

§ North America (US,Canada)

§ Europe (UK, France,Germany, Italy, Spain and rest of the Europe)

§ Asia-Pacific (Japan,China, South Korea, India and Australia)

 

The BiologicsFill / Finish Services Market, 2020-2030 report features the following companies, which weidentified to be key players in this domain:

§  Advanced BioScience Laboratories (ABL)

§  Albany Molecular Research (AMRI)

§  Biocon

§  BioPharma Solutions

§  BioReliance

§  Boehringer Ingelheim BioXcellence

§  ChemPartner

§  Emergent BioSolutions

§  IDT Biologika

§  Lonza

§  LuinaBio

§  Mycenax Biotech

§  Patheon

§  Recipharm

§  Vetter Pharma

§  WuXi Biologics

 

Table of Contents

 

1. Preface

2. Executive Summary


3. Introduction

4. Competitive Landscape

5. Company Competitiveness Analysis

6. Biologics Fill / Finish Service Providers in North America:Company Profiles

7. Biologics Fill / Finish Service Providers in Europe:Company Profiles 

8. Biologics Fill / Finish Service Providers inAsia-Pacific: Company Profiles

9. Partnerships and Collaborations

10. Recent Expansions

11. Capacity Analysis

12. Demand Analysis

13. Biologics Manufacturing and Fill / Finish: KeyPerformance Indicator Analysis

14. Market Sizing and Opportunity Analysis

 

15. Future Growth Opportunities

 

16. Case Study: Robotic Systems in Fill / Finish Operations

 

17. Case Study: Ready-to-Use Packaging Components inAseptic Fill / Finish Operations

 

18. Conclusion

 

19. Interview Transcripts

 

20. Appendix 1: Tabulated Data

 

21. Appendix 2: List of Companies and Organizations

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/biologics-fill--finish-services-market-2019-2030/256.html

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com